These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37300293)

  • 21. Testing alternatives: the use of adipose-derived mesenchymal stem cells to slow neurodegeneration in a rat model of Parkinson's disease.
    Meligy FY; Elgamal DA; Abd Allah ESH; Idriss NK; Ghandour NM; Bayoumy EMR; Khalil ASA; El Fiky MM; Elkhashab M
    Mol Biol Rep; 2019 Dec; 46(6):5841-5858. PubMed ID: 31396803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
    Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA
    Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin-pretreated adipose-derived mesenchymal stem cells efficeintly improved learning, memory, and cognition in an animal model of Alzheimer's disease.
    Nasiri E; Alizadeh A; Roushandeh AM; Gazor R; Hashemi-Firouzi N; Golipoor Z
    Metab Brain Dis; 2019 Aug; 34(4):1131-1143. PubMed ID: 31129766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
    Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
    Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease.
    Salama M; Sobh M; Emam M; Abdalla A; Sabry D; El-Gamal M; Lotfy A; El-Husseiny M; Sobh M; Shalash A; Mohamed WM
    Exp Ther Med; 2017 Mar; 13(3):976-982. PubMed ID: 28450929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. bFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson's disease.
    Xiong N; Yang H; Liu L; Xiong J; Zhang Z; Zhang X; Jia M; Huang J; Zhang Z; Mohamed AA; Lin Z; Wang T
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):411-422. PubMed ID: 23770451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of RET and GDNF family receptor, GFR-α1, between striatum and substantia nigra following nigrostriatal lesion: a case for diminished GDNF-signaling.
    Kasanga EA; Han Y; Navarrete W; McManus R; Shifflet MK; Parry C; Barahona A; Manfredsson FP; Nejtek VA; Richardson JR; Salvatore MF
    bioRxiv; 2023 Mar; ():. PubMed ID: 36909534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitrosative and cognitive effects of chronic L-DOPA administration in rats with intra-nigral 6-OHDA lesion.
    Ramírez-García G; Palafox-Sánchez V; Limón ID
    Neuroscience; 2015 Apr; 290():492-508. PubMed ID: 25644418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Expression of Neuronal Dopaminergic Markers in a Parkinson's Disease Model in Rats Implanted with Enteric Stem Cells (ENSCs).
    Parra-Cid C; Orozco-Castillo E; García-López J; Contreras-Figueroa E; Ramos-Languren LE; Ibarra C; Carreón-Rodríguez A; Aschner M; Königsberg M; Santamaría A
    CNS Neurol Disord Drug Targets; 2020; 19(2):148-162. PubMed ID: 32303175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cells that located in the electromagnetic fields improves rat model of Parkinson's disease.
    Jadidi M; Biat SM; Sameni HR; Safari M; Vafaei AA; Ghahari L
    Iran J Basic Med Sci; 2016 Jul; 19(7):741-8. PubMed ID: 27635198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
    Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
    Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes.
    Bigham M; Mohammadipour A; Hosseini M; Malvandi AM; Ebrahimzadeh-Bideskan A
    Metab Brain Dis; 2021 Jun; 36(5):927-937. PubMed ID: 33656625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.
    Wang F; Yasuhara T; Shingo T; Kameda M; Tajiri N; Yuan WJ; Kondo A; Kadota T; Baba T; Tayra JT; Kikuchi Y; Miyoshi Y; Date I
    BMC Neurosci; 2010 Apr; 11():52. PubMed ID: 20420688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of allogeneic bone marrow derived mesenchymal stromal cell therapy on voiding function in a rat model of Parkinson disease.
    Campeau L; Soler R; Sittadjody S; Pareta R; Nomiya M; Zarifpour M; Opara EC; Yoo JJ; Andersson KE
    J Urol; 2014 Mar; 191(3):850-9. PubMed ID: 23973520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
    Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
    Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson's Disease Mouse Model.
    Park H; Chang KA
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase.
    Watts PM; Riedl AG; Douek DC; Edwards RJ; Boobis AR; Jenner P; Marsden CD
    Neuroscience; 1998 Sep; 86(2):511-9. PubMed ID: 9881865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease.
    Simorgh S; Alizadeh R; Shabani R; Karimzadeh F; Seidkhani E; Majidpoor J; Moradi F; Kasbiyan H
    Neurotox Res; 2021 Jun; 39(3):598-608. PubMed ID: 33433781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adenovirus mediated vascular endothelial growth factor gene transfer protects dopaminergic neurons in Parkinson's disease: experiment with rats].
    Tian YY; Sun SG; Wang JN; Tang CJ; Feng Y; Wang L; Chen XW; Qiao X
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(29):2054-9. PubMed ID: 17064552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.